Imago BioSciences Inc. (IMGO) NASDAQ
$36.01 0.01 (0.03%)
Market Cap: -
As of 01/10/23 04:00 PM EST. Market closed.
Imago BioSciences Inc. (IMGO)
NASDAQ
$36.01
0.01 (0.03%)
Market Cap: -
As of 01/10/23 04:00 PM EST. Market closed.
Imago BioSciences is a clinical-stage biopharmaceutical company discovering and developing novel small molecule product candidates that target lysine-specific demethylase 1 (LSD1), an enzyme that plays a central role in the production of blood cells in the bone marrow. Imago is focused on improving the quality and length of life for patients with cancer and bone marrow diseases. Bomedemstat, an ... read more
Imago BioSciences is a clinical-stage biopharmaceutical company discovering and developing novel small molecule product candidates that target lysine-specific demethylase 1 (LSD1), an enzyme that plays a central role in the production of blood cells in the bone marrow. Imago is focused on improving the quality and length of life for patients with cancer and bone marrow diseases. Bomedemstat, an orally available, small molecule inhibitor of LSD1, is the lead product candidate discovered by Imago for the treatment of certain myeloproliferative neoplasms (MPNs), a family of related, chronic cancers of the bone marrow. Imago is evaluating Bomedemstat as a potentially disease-modifying therapy in two Phase 2 clinical trials for the treatment of essential thrombocythemia (NCT04254978) and myelofibrosis (NCT03136185). Bomedemstat has U.S. FDA Orphan Drug and Fast Track Designation for the treatment of ET and MF, European Medicines Agency (EMA) Orphan Designation for the treatment of ET and MF, and PRIority MEdicines (PRIME) Designation by the EMA for the treatment of MF. The company is based in South San Francisco, California. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Tapper Amy E. | Chief, Technical Operations | Jan 11, 2023 | Option Exercise | $36.00 | 141,094 | 5,079,384 | 0 | Jan 11, 2023, 04:19 PM |
Rienhoff Hugh JR | Chief Executive Officer | Jan 11, 2023 | Option Exercise | $36.00 | 501,702 | 18,061,272 | 0 | Jan 11, 2023, 04:17 PM |
Eichorn Laura G. | Chief Financial Officer | Jan 11, 2023 | Option Exercise | $36.00 | 246,453 | 8,872,308 | 0 | Jan 11, 2023, 04:17 PM |
HENNER DENNIS | Director | Jan 11, 2023 | Option Exercise | $36.00 | 26,095 | 939,420 | 0 | Jan 11, 2023, 04:16 PM |
Arenberg Michael | See Remarks | Jan 11, 2023 | Option Exercise | $36.00 | 51,532 | 1,855,152 | 0 | Jan 11, 2023, 04:16 PM |
Chiang Hsiangyi | Senior Vice President, Finance | Jan 11, 2023 | Option Exercise | $36.00 | 26,538 | 955,368 | 0 | Jan 11, 2023, 04:13 PM |
Peppe Jennifer | See Remarks | Jan 11, 2023 | Option Exercise | $36.00 | 150,188 | 5,406,768 | 0 | Jan 11, 2023, 04:12 PM |
Baltera Robert Jr. | Director | Jan 11, 2023 | Option Exercise | $36.00 | 850 | 30,600 | 0 | Jan 11, 2023, 04:10 PM |
Chiang Hsiangyi | Senior Vice President Finance | Jan 04, 2023 | Option Exercise | $4.20 | 19,941 | 83,752 | 26,538 | Jan 05, 2023, 04:31 PM |
Arenberg Michael | See Remarks | Jan 03, 2023 | Option Exercise | $15.45 | 2,145 | 33,140 | 51,532 | Jan 05, 2023, 04:30 PM |
Peppe Jennifer | See Remarks | Jan 03, 2023 | Option Exercise | $22.76 | 1,379 | 31,386 | 150,188 | Jan 05, 2023, 04:29 PM |
Eichorn Laura G. | Chief Financial Officer | Jan 03, 2023 | Option Exercise | $4.05 | 37,119 | 150,176 | 246,453 | Jan 05, 2023, 04:29 PM |
Tapper Amy E. | See Remarks | Jan 03, 2023 | Option Exercise | $4.81 | 21,261 | 102,321 | 141,094 | Jan 05, 2023, 04:28 PM |
Rienhoff Hugh JR | Chief Executive Officer | Jan 03, 2023 | Option Exercise | $2.52 | 12,176 | 30,684 | 501,702 | Jan 05, 2023, 04:27 PM |
Eichorn Laura G. | Chief Financial Officer | Dec 27, 2022 | Option Exercise | $2.52 | 3,100 | 7,812 | 210,837 | Dec 29, 2022, 04:07 PM |
Eichorn Laura G. | Chief Financial Officer | Dec 27, 2022 | Sale | $35.93 | 3,100 | 111,384 | 207,737 | Dec 29, 2022, 04:07 PM |
Arenberg Michael | See Remarks | Dec 27, 2022 | Option Exercise | $17.55 | 95,000 | 1,667,464 | 119,895 | Dec 29, 2022, 04:06 PM |
Arenberg Michael | See Remarks | Dec 27, 2022 | Sale | $35.93 | 70,508 | 2,533,352 | 49,387 | Dec 29, 2022, 04:06 PM |
Tapper Amy E. | See Remarks | Dec 16, 2022 | Option Exercise | $2.19 | 100,302 | 219,819 | 219,349 | Dec 20, 2022, 04:19 PM |
Tapper Amy E. | See Remarks | Dec 16, 2022 | Sale | $35.78 | 100,302 | 3,588,725 | 119,047 | Dec 20, 2022, 04:19 PM |
Arenberg Michael | See Remarks | Dec 16, 2022 | Option Exercise | $15.45 | 72,645 | 1,122,365 | 72,645 | Dec 20, 2022, 04:18 PM |
Arenberg Michael | See Remarks | Dec 16, 2022 | Sale | $35.78 | 47,750 | 1,708,500 | 24,895 | Dec 20, 2022, 04:18 PM |
Peppe Jennifer | See Remarks | Dec 15, 2022 | Option Exercise | $4.45 | 119,422 | 532,008 | 268,231 | Dec 19, 2022, 04:27 PM |
Peppe Jennifer | See Remarks | Dec 15, 2022 | Sale | $35.80 | 119,422 | 4,275,236 | 148,809 | Dec 19, 2022, 04:27 PM |
Peppe Jennifer | See Remarks | Dec 15, 2022 | Option Exercise | $4.45 | 119,422 | 532,008 | 268,231 | Dec 19, 2022, 04:19 PM |
Peppe Jennifer | See Remarks | Dec 15, 2022 | Sale | $35.80 | 119,422 | 4,275,236 | 148,809 | Dec 19, 2022, 04:19 PM |
Rienhoff Hugh JR | Chief Executive Officer | Dec 15, 2022 | Option Exercise | $2.18 | 206,309 | 449,246 | 695,835 | Dec 19, 2022, 04:11 PM |
Rienhoff Hugh JR | Chief Executive Officer | Dec 16, 2022 | Option Exercise | $2.14 | 266,784 | 572,127 | 756,310 | Dec 19, 2022, 04:11 PM |
Rienhoff Hugh JR | Chief Executive Officer | Dec 15, 2022 | Sale | $35.80 | 206,309 | 7,385,945 | 489,526 | Dec 19, 2022, 04:11 PM |
Rienhoff Hugh JR | Chief Executive Officer | Dec 16, 2022 | Sale | $35.78 | 266,784 | 9,545,078 | 489,526 | Dec 19, 2022, 04:11 PM |
Eichorn Laura G. | Chief Financial Officer | Dec 15, 2022 | Option Exercise | $2.21 | 126,714 | 279,813 | 334,451 | Dec 19, 2022, 04:10 PM |
Eichorn Laura G. | Chief Financial Officer | Dec 15, 2022 | Sale | $35.79 | 126,714 | 4,535,170 | 207,737 | Dec 19, 2022, 04:10 PM |
Tapper Amy E. | See Remarks | Nov 02, 2022 | Option Exercise | $2.52 | 750 | 1,890 | 119,797 | Nov 04, 2022, 08:20 PM |
Tapper Amy E. | See Remarks | Nov 02, 2022 | Sale | $17.90 | 750 | 13,425 | 119,047 | Nov 04, 2022, 08:20 PM |
Eichorn Laura G. | Chief Financial Officer | Nov 02, 2022 | Option Exercise | $2.52 | 553 | 1,394 | 208,290 | Nov 04, 2022, 08:18 PM |
Eichorn Laura G. | Chief Financial Officer | Nov 02, 2022 | Sale | $18.00 | 553 | 9,954 | 207,737 | Nov 04, 2022, 08:18 PM |
Eichorn Laura G. | Chief Financial Officer | Aug 22, 2022 | Option Exercise | $2.52 | 447 | 1,126 | 208,184 | Aug 24, 2022, 06:24 PM |
Eichorn Laura G. | Chief Financial Officer | Aug 22, 2022 | Sale | $18.00 | 447 | 8,046 | 207,737 | Aug 24, 2022, 06:24 PM |
Eichorn Laura G. | See Remarks | Aug 16, 2022 | Option Exercise | $2.52 | 533 | 1,343 | 208,270 | Aug 18, 2022, 05:50 PM |
Eichorn Laura G. | See Remarks | Aug 17, 2022 | Option Exercise | $2.52 | 373 | 940 | 208,110 | Aug 18, 2022, 05:50 PM |
Eichorn Laura G. | See Remarks | Aug 17, 2022 | Sale | $19.50 | 373 | 7,274 | 207,737 | Aug 18, 2022, 05:50 PM |
Eichorn Laura G. | See Remarks | Aug 16, 2022 | Sale | $19.50 | 533 | 10,394 | 207,737 | Aug 18, 2022, 05:50 PM |
Peppe Jennifer | See Remarks | Aug 16, 2022 | Option Exercise | $2.52 | 6,402 | 16,133 | 155,211 | Aug 17, 2022, 05:05 PM |
Peppe Jennifer | See Remarks | Aug 16, 2022 | Sale | $19.41 | 6,402 | 124,280 | 148,809 | Aug 17, 2022, 05:05 PM |
Peppe Jennifer | See Remarks | Aug 15, 2022 | Option Exercise | $2.52 | 5,598 | 14,107 | 154,407 | Aug 16, 2022, 04:08 PM |
Peppe Jennifer | See Remarks | Aug 15, 2022 | Sale | $19.41 | 5,598 | 108,636 | 148,809 | Aug 16, 2022, 04:08 PM |
Tapper Amy E. | See Remarks | Aug 15, 2022 | Option Exercise | $2.52 | 11,500 | 28,980 | 130,547 | Aug 16, 2022, 04:06 PM |
Tapper Amy E. | See Remarks | Aug 12, 2022 | Option Exercise | $2.52 | 750 | 1,890 | 119,797 | Aug 16, 2022, 04:06 PM |
Tapper Amy E. | See Remarks | Aug 12, 2022 | Sale | $17.90 | 750 | 13,425 | 119,047 | Aug 16, 2022, 04:06 PM |
Tapper Amy E. | See Remarks | Aug 15, 2022 | Sale | $19.26 | 11,500 | 221,545 | 119,047 | Aug 16, 2022, 04:06 PM |
Eichorn Laura G. | See Remarks | Jul 20, 2022 | Option Exercise | $2.52 | 1,000 | 2,520 | 208,737 | Jul 21, 2022, 05:50 PM |
Eichorn Laura G. | See Remarks | Jul 20, 2022 | Sale | $18.00 | 1,000 | 18,000 | 207,737 | Jul 21, 2022, 05:50 PM |
Tapper Amy E. | See Remarks | Jul 20, 2022 | Option Exercise | $2.52 | 750 | 1,890 | 119,797 | Jul 21, 2022, 05:49 PM |
Tapper Amy E. | See Remarks | Jul 20, 2022 | Sale | $17.90 | 750 | 13,425 | 119,047 | Jul 21, 2022, 05:49 PM |
Hong Wan-Jen | Chief Medical Officer | Jul 18, 2022 | Option Exercise | $7.06 | 1,000 | 7,060 | 1,000 | Jul 20, 2022, 05:39 PM |
Eichorn Laura G. | See Remarks | Feb 22, 2022 | Option Exercise | $2.52 | 8,000 | 20,160 | 215,737 | Feb 24, 2022, 06:05 PM |
Eichorn Laura G. | See Remarks | Feb 22, 2022 | Sale | $21.60 | 8,000 | 172,813 | 208,137 | Feb 24, 2022, 06:05 PM |
Peppe Jennifer | See Remarks | Feb 11, 2022 | Option Exercise | $2.10 | 7,000 | 14,700 | 155,809 | Feb 15, 2022, 04:26 PM |
Peppe Jennifer | See Remarks | Feb 11, 2022 | Sale | $23.76 | 7,000 | 166,295 | 148,809 | Feb 15, 2022, 04:26 PM |
Eichorn Laura G. | See Remarks | Feb 11, 2022 | Option Exercise | $1.52 | 4,000 | 6,080 | 211,737 | Feb 15, 2022, 04:25 PM |
Eichorn Laura G. | See Remarks | Feb 11, 2022 | Sale | $23.61 | 4,000 | 94,455 | 207,737 | Feb 15, 2022, 04:25 PM |
Peppe Jennifer | See Remarks | Feb 09, 2022 | Option Exercise | $1.86 | 10,000 | 18,574 | 158,809 | Feb 11, 2022, 04:23 PM |
Peppe Jennifer | See Remarks | Feb 09, 2022 | Sale | $22.26 | 10,000 | 222,581 | 148,809 | Feb 11, 2022, 04:23 PM |
Eichorn Laura G. | See Remarks | Feb 09, 2022 | Option Exercise | $1.52 | 4,000 | 6,080 | 211,737 | Feb 11, 2022, 04:22 PM |
Eichorn Laura G. | See Remarks | Feb 09, 2022 | Sale | $21.56 | 4,000 | 86,254 | 207,737 | Feb 11, 2022, 04:22 PM |
Tapper Amy E. | See Remarks | Feb 09, 2022 | Option Exercise | $1.52 | 3,000 | 4,560 | 122,047 | Feb 11, 2022, 04:21 PM |
Tapper Amy E. | See Remarks | Feb 09, 2022 | Sale | $21.54 | 3,000 | 64,614 | 119,047 | Feb 11, 2022, 04:21 PM |
Peppe Jennifer | See Remarks | Feb 07, 2022 | Option Exercise | $1.98 | 13,000 | 25,760 | 161,809 | Feb 09, 2022, 04:06 PM |
Peppe Jennifer | See Remarks | Feb 07, 2022 | Sale | $20.48 | 13,000 | 266,202 | 154,709 | Feb 09, 2022, 04:06 PM |
Tapper Amy E. | See Remarks | Feb 01, 2022 | Option Exercise | $2.10 | 6,500 | 13,650 | 125,547 | Feb 03, 2022, 04:13 PM |
Tapper Amy E. | See Remarks | Feb 01, 2022 | Sale | $19.76 | 6,500 | 128,412 | 119,797 | Feb 03, 2022, 04:13 PM |
Peppe Jennifer | See Remarks | Jan 12, 2022 | Option Exercise | $1.79 | 14,000 | 25,059 | 162,809 | Jan 14, 2022, 06:48 PM |
Peppe Jennifer | See Remarks | Jan 12, 2022 | Sale | $19.95 | 14,000 | 279,353 | 148,809 | Jan 14, 2022, 06:48 PM |
Tapper Amy E. | See Remarks | Jan 12, 2022 | Option Exercise | $1.52 | 6,000 | 9,120 | 125,047 | Jan 14, 2022, 06:47 PM |
Tapper Amy E. | See Remarks | Jan 12, 2022 | Sale | $19.96 | 6,000 | 119,750 | 119,047 | Jan 14, 2022, 06:47 PM |
Eichorn Laura G. | See Remarks | Jan 12, 2022 | Option Exercise | $1.52 | 8,000 | 12,160 | 215,737 | Jan 14, 2022, 06:46 PM |
Eichorn Laura G. | See Remarks | Jan 12, 2022 | Sale | $19.96 | 8,000 | 159,651 | 207,737 | Jan 14, 2022, 06:46 PM |
Clarus Lifesciences III, L.P. | 10% Owner | Jul 20, 2021 | Buy | $16.00 | 150,000 | 2,400,000 | 3,375,037 | Jul 20, 2021, 06:05 PM |
Heron Patrick J | Director | Jul 20, 2021 | Buy | $16.00 | 187,500 | 3,000,000 | 145,918 | Jul 20, 2021, 05:54 PM |
Omega Fund VI, L.P. | Former 10% owner | Jul 15, 2021 | Buy | $16.00 | 250,000 | 4,000,000 | 250,000 | Jul 19, 2021, 07:03 PM |
Baltera Robert Jr. | Director | Jul 15, 2021 | Buy | $16.00 | 850 | 13,600 | 850 | Jul 19, 2021, 04:09 PM |
Owner | Relationship | Date | Value($) |
Tapper Amy E. | Chief, Technical Operations | 01/11/2023 | 5,079,384 |
Rienhoff Hugh JR | Chief Executive Officer | 01/11/2023 | 18,061,272 |
Eichorn Laura G. | Chief Financial Officer | 01/11/2023 | 8,872,308 |
HENNER DENNIS | Director | 01/11/2023 | 939,420 |
Arenberg Michael | See Remarks | 01/11/2023 | 1,855,152 |
Chiang Hsiangyi | Senior Vice President, Finance | 01/11/2023 | 955,368 |
Peppe Jennifer | See Remarks | 01/11/2023 | 5,406,768 |
Baltera Robert Jr. | Director | 01/11/2023 | 30,600 |
Chiang Hsiangyi | Senior Vice President Finance | 01/04/2023 | 83,752 |
Arenberg Michael | See Remarks | 01/03/2023 | 33,140 |
Peppe Jennifer | See Remarks | 01/03/2023 | 31,386 |
Eichorn Laura G. | Chief Financial Officer | 01/03/2023 | 150,176 |
Tapper Amy E. | See Remarks | 01/03/2023 | 102,321 |
Rienhoff Hugh JR | Chief Executive Officer | 01/03/2023 | 30,684 |
Eichorn Laura G. | Chief Financial Officer | 12/27/2022 | 7,812 |
Eichorn Laura G. | Chief Financial Officer | 12/27/2022 | 111,384 |
Arenberg Michael | See Remarks | 12/27/2022 | 1,667,464 |
Arenberg Michael | See Remarks | 12/27/2022 | 2,533,352 |
Tapper Amy E. | See Remarks | 12/16/2022 | 219,819 |
Tapper Amy E. | See Remarks | 12/16/2022 | 3,588,725 |
Arenberg Michael | See Remarks | 12/16/2022 | 1,122,365 |
Arenberg Michael | See Remarks | 12/16/2022 | 1,708,500 |
Peppe Jennifer | See Remarks | 12/15/2022 | 532,008 |
Peppe Jennifer | See Remarks | 12/15/2022 | 4,275,236 |
Peppe Jennifer | See Remarks | 12/15/2022 | 532,008 |
Peppe Jennifer | See Remarks | 12/15/2022 | 4,275,236 |
Rienhoff Hugh JR | Chief Executive Officer | 12/15/2022 | 449,246 |
Rienhoff Hugh JR | Chief Executive Officer | 12/16/2022 | 572,127 |
Rienhoff Hugh JR | Chief Executive Officer | 12/15/2022 | 7,385,945 |
Rienhoff Hugh JR | Chief Executive Officer | 12/16/2022 | 9,545,078 |
Eichorn Laura G. | Chief Financial Officer | 12/15/2022 | 279,813 |
Eichorn Laura G. | Chief Financial Officer | 12/15/2022 | 4,535,170 |
Tapper Amy E. | See Remarks | 11/02/2022 | 1,890 |
Tapper Amy E. | See Remarks | 11/02/2022 | 13,425 |
Eichorn Laura G. | Chief Financial Officer | 11/02/2022 | 1,394 |
Eichorn Laura G. | Chief Financial Officer | 11/02/2022 | 9,954 |
Eichorn Laura G. | Chief Financial Officer | 08/22/2022 | 1,126 |
Eichorn Laura G. | Chief Financial Officer | 08/22/2022 | 8,046 |
Eichorn Laura G. | See Remarks | 08/16/2022 | 1,343 |
Eichorn Laura G. | See Remarks | 08/17/2022 | 940 |
Eichorn Laura G. | See Remarks | 08/17/2022 | 7,274 |
Eichorn Laura G. | See Remarks | 08/16/2022 | 10,394 |
Peppe Jennifer | See Remarks | 08/16/2022 | 16,133 |
Peppe Jennifer | See Remarks | 08/16/2022 | 124,280 |
Peppe Jennifer | See Remarks | 08/15/2022 | 14,107 |
Peppe Jennifer | See Remarks | 08/15/2022 | 108,636 |
Tapper Amy E. | See Remarks | 08/15/2022 | 28,980 |
Tapper Amy E. | See Remarks | 08/12/2022 | 1,890 |
Tapper Amy E. | See Remarks | 08/12/2022 | 13,425 |
Tapper Amy E. | See Remarks | 08/15/2022 | 221,545 |
Eichorn Laura G. | See Remarks | 07/20/2022 | 2,520 |
Eichorn Laura G. | See Remarks | 07/20/2022 | 18,000 |
Tapper Amy E. | See Remarks | 07/20/2022 | 1,890 |
Tapper Amy E. | See Remarks | 07/20/2022 | 13,425 |
Hong Wan-Jen | Chief Medical Officer | 07/18/2022 | 7,060 |
Eichorn Laura G. | See Remarks | 02/22/2022 | 20,160 |
Eichorn Laura G. | See Remarks | 02/22/2022 | 172,813 |
Peppe Jennifer | See Remarks | 02/11/2022 | 14,700 |
Peppe Jennifer | See Remarks | 02/11/2022 | 166,295 |
Eichorn Laura G. | See Remarks | 02/11/2022 | 6,080 |
Eichorn Laura G. | See Remarks | 02/11/2022 | 94,455 |
Peppe Jennifer | See Remarks | 02/09/2022 | 18,574 |
Peppe Jennifer | See Remarks | 02/09/2022 | 222,581 |
Eichorn Laura G. | See Remarks | 02/09/2022 | 6,080 |
Eichorn Laura G. | See Remarks | 02/09/2022 | 86,254 |
Tapper Amy E. | See Remarks | 02/09/2022 | 4,560 |
Tapper Amy E. | See Remarks | 02/09/2022 | 64,614 |
Peppe Jennifer | See Remarks | 02/07/2022 | 25,760 |
Peppe Jennifer | See Remarks | 02/07/2022 | 266,202 |
Tapper Amy E. | See Remarks | 02/01/2022 | 13,650 |
Tapper Amy E. | See Remarks | 02/01/2022 | 128,412 |
Peppe Jennifer | See Remarks | 01/12/2022 | 25,059 |
Peppe Jennifer | See Remarks | 01/12/2022 | 279,353 |
Tapper Amy E. | See Remarks | 01/12/2022 | 9,120 |
Tapper Amy E. | See Remarks | 01/12/2022 | 119,750 |
Eichorn Laura G. | See Remarks | 01/12/2022 | 12,160 |
Eichorn Laura G. | See Remarks | 01/12/2022 | 159,651 |
Clarus Lifesciences III, L.P. | 10% Owner | 07/20/2021 | 2,400,000 |
Heron Patrick J | Director | 07/20/2021 | 3,000,000 |
Omega Fund VI, L.P. | Former 10% owner | 07/15/2021 | 4,000,000 |
Baltera Robert Jr. | Director | 07/15/2021 | 13,600 |